• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2019

View Archived Issues

First patient dosed in phase II study of IMB-115

Read More

18F-Labeled PSMA ligand development leads to clinical candidate [18F]siPSMA-14

Read More

Brain axonal iron transport modulates anxiety-related behaviors

Read More

Enhancing PGK1 activity and increasing glycolysis may slow neurodegeneration in Parkinson's disease

Read More

SCO-792, a novel small-molecule enteropeptidase inhibitor blocking protein digestion in vivo

Read More

Dosing begins in NIH-funded phase II proof-of-concept study of ANS-6637

Read More

Interim data reported from BRIDGE phase III study of pegunigalsidase alpha in Fabry disease

Read More

Phase III BE VIVID study of bimekizumab in psoriasis meets all endpoints

Read More

Syros discontinues SY-1365 and focuses on the development of SY-5609

Read More

Topline results presented from first cohort of phase II study of low-dose inarigivir plus Vemlidy

Read More

First-in-human data presented for [99mTc]-ADAPT6

Read More

Bioevaluation of novel TSPO-selective PET probe, [18F]BS-224

Read More

Synthesis and characterization of novel N-carboxymethyl-substituted PSMA ligands

Read More

Medshine Discovery presents new dual SGLT1 and SGLT2 inhibitors

Read More

New FGFR inhibitors described by the Shanghai Institute of Organic Chemistry

Read More

Shanghai Meiyue Biotech Development discovers thrombin and factor XIa inhibitors

Read More

New apoptosis regulator Bcl-2 inhibitors disclosed by Jiangsu Chia Tai Tianqing Pharmaceutical Group

Read More

Shanghai Institute of Materia Medica and Jinan University patent AXL and/or FLT3 inhibitors

Read More

TAP downregulation by an aptamer-siRNA conjugate could potentiate responsiveness to immune therapy

Read More

New potent and selective ROS1/TRK family inhibitor is effective in crizotinib-resistant models

Read More

Novel albumin-binding agents for FAP-targeted radionuclide therapy presented

Read More

FDA approves Xofluza to treat influenza in those at high risk of influenza complications

Read More

Spring Bank initiates phase I study of SB-11285 alone and with nivolumab in solid tumors

Read More

SHARPIN gene variant linked to late-onset Alzheimer's disease in Japanese subjects

Read More

Scientists tie novel genetic variant in RBMX2 gene to bipolar disorder

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe